Jonathan Ilicki
Investment Manager
Joined: 2023
Involved in: BOOST Pharma, Tribune Therapeutics, Gesynta, Elypta, Airsonett, NuvoAir, Zymego, ToxoTech, Asgard Therapeutics
Interests: Diagnostics, HealthTech, MedTech, Therapeutics, Science Tools
Jonathan is part of Industrifonden’s life science team, combining experience from clinical practice, research, entrepreneurship, and management consulting.
Prior to joining Industrifonden, he worked as a physician and co‑founded a medtech startup. He has also built and scaled operations for a digital healthcare provider, and led growth and internationalization for a VC/PE‑backed healthtech scale‑up. In addition, he has served as a coach and strategic advisor to several life science and technology companies.
Jonathan holds an MD from Karolinska Institutet and an Executive MBA from the Stockholm School of Economics. He also holds a master’s degree in Evidence‑Based Medicine from the University of Gothenburg and is a Clinical Innovation Fellow at the KTH Royal Institute of Technology. He is a Marshall Memorial Fellow and, in 2024, was selected as a Europe Leader by the Obama Foundation.